Literature DB >> 1319520

Carbamylation-induced alterations in low-density lipoprotein metabolism.

S Hörkkö1, M J Savolainen, K Kervinen, Y A Kesäniemi.   

Abstract

Low-density lipoprotein was derived from carbamyl (carbamyl-LDL) by incubating LDL in potassium cyanate (KCNO). The proportion of free amino groups in the carbamyl-LDL was negatively correlated (r = -0.95) with the time of incubation in potassium cyanate (ranged from 5 to 360 min). The carbamylation did not change the chemical composition or the flotation characteristics of the LDL particles. However, the electrophoretic mobility of carbamyl-LDL was distinctly increased with the extent of carbamylation. The carbamyl-LDL had substantially decreased binding to the LDL apoB/E receptors of the bovine adrenocortical membranes when compared to the control-LDL. The reduced binding was already observed when only 9% of the free amino groups were derived from carbamyl. A minor carbamylation of LDL (less than 20% of the free amino groups) decreased the in vivo clearance of LDL from rabbit plasma. However, when more than 20% of the free amino groups were derived the carbamyl-LDL had accelerated clearance compared to the control-LDL. LDL isolated from uremic patients was cleared in rabbits at a slower rate than LDL isolated from a control subject. Providing that carbamylation of LDL could also occur in vivo resulting in similar alterations of the LDL binding to the LDL B/E receptors, as observed in the present study, the uremia-related accelerated atherosclerosis could have one additional mechanistic explanation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319520     DOI: 10.1038/ki.1992.179

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

Review 1.  Mechanisms and consequences of carbamoylation.

Authors:  Sigurd Delanghe; Joris R Delanghe; Reinhart Speeckaert; Wim Van Biesen; Marijn M Speeckaert
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

2.  Effects of amino acids and albumin on erythropoietin carbamoylation.

Authors:  Kyubok Jin
Journal:  Clin Exp Nephrol       Date:  2012-12-11       Impact factor: 2.801

3.  Protein carbamylation in chronic systolic heart failure: relationship with renal impairment and adverse long-term outcomes.

Authors:  W H Wilson Tang; Kevin Shrestha; Zeneng Wang; Allen G Borowski; Richard W Troughton; Allan L Klein; Stanley L Hazen
Journal:  J Card Fail       Date:  2013-03-19       Impact factor: 5.712

4.  Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL.

Authors:  Eugene O Apostolov; Sudhir V Shah; Debarti Ray; Alexei G Basnakian
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-20       Impact factor: 8.311

5.  Carbamylated-oxidized LDL: proatherosclerotic effects on endothelial cells and macrophages.

Authors:  Eugene O Apostolov; Ercan Ok; Samuel Burns; Safia Nawaz; Alena Savenka; Sudhir V Shah; Alexei G Basnakian
Journal:  J Atheroscler Thromb       Date:  2013-09-25       Impact factor: 4.928

6.  Glutaraldehyde erythropoietin protects kidney in ischaemia/reperfusion injury without increasing red blood cell production.

Authors:  S Chattong; J Tanamai; P Kiatsomchai; M Nakatsu; A Sereemaspun; N Pimpha; K Praditpornsilpa; R Rojanathanes; A Sethpakadee; K Tungsanga; S Eiam-Ong; K Manotham
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

7.  Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adducts.

Authors:  Outi Kummu; S Pauliina Turunen; Piotr Prus; Jaakko Lehtimäki; Marja Veneskoski; Chunguang Wang; Sohvi Hörkkö
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

8.  Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study.

Authors:  Sahir Kalim; Anders H Berg; Subbian Ananth Karumanchi; Ravi Thadhani; Andrew S Allegretti; Sagar Nigwekar; Sophia Zhao; Anand Srivastava; Dominic Raj; Rajat Deo; Anne Frydrych; Jing Chen; James Sondheimer; Tariq Shafi; Matthew Weir; James P Lash
Journal:  Nephrol Dial Transplant       Date:  2021-12-31       Impact factor: 7.186

Review 9.  Protein carbamylation in kidney disease: pathogenesis and clinical implications.

Authors:  Sahir Kalim; S Ananth Karumanchi; Ravi I Thadhani; Anders H Berg
Journal:  Am J Kidney Dis       Date:  2014-07-16       Impact factor: 8.860

10.  Comparison of Neurite Outgrowth Induced by Erythropoietin (EPO) and Carbamylated Erythropoietin (CEPO) in Hippocampal Neural Progenitor Cells.

Authors:  Dong Hoon Oh; In Young Lee; Miyeon Choi; Seok Hyeon Kim; Hyeon Son
Journal:  Korean J Physiol Pharmacol       Date:  2012-08-10       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.